Global Pharmaceutical Cdmo Market Size & Outlook
Global pharmaceutical cdmo market, 2018-2030 (US$M)
Related Markets
Global pharmaceutical cdmo market highlights
- The global pharmaceutical cdmo market generated a revenue of USD 145,997.4 million in 2023 and is expected to reach USD 235,524.6 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 7.1% by 2030.
- In terms of segment, api accounted for a revenue of USD 118,550.9 million in 2023.
- API is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 145,997.4 million |
| Market revenue in 2030 | USD 235,524.6 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Api |
| Fastest growing segment | API |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | API, Drug Product |
Other key industry trends
- In terms of revenue, the North America accounted for 25.6% of the global pharmaceutical cdmo market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 1,137.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical CDMO Market Scope
Pharmaceutical CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global pharmaceutical cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical cdmo market will help companies and investors design strategic landscapes.
Api was the largest segment with a revenue share of 81.2% in 2023. Horizon Databook has segmented the Global pharmaceutical cdmo market based on api, drug product covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Pharmaceutical CDMO Product Outlook (Revenue, USD Million, 2018-2030)
- API
- Synthetic
- Solid
- Liquid
- Biotech
- Synthetic
- Drug Product
- Oral Solid Dose
- Semi-solid Dose
- Liquid Dose
- Others
- API
- Global Pharmaceutical CDMO Work Flow Outlook (Revenue, USD Million, 2018-2030)
- Clinical
- Commercial
- Global Pharmaceutical CDMO Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Small Molecule
- Biologics
- Infectious Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Metabolic Disorders
- Autoimmune Diseases
- Respiratory Diseases
- Ophthalmology
- Gastrointestinal Disorders
- Hormonal Disorders
- Hematological Disorders
- Others
- Oncology
Reasons to subscribe to Global pharmaceutical cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmaceutical cdmo market databook
-
Our clientele includes a mix of pharmaceutical cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmaceutical cdmo market size, by regions, 2018-2030 (US$M)
Top 10 countries: Pharmaceutical cdmo market size, 2023 (US$M)
Global pharmaceutical cdmo market share, by product, 2023 & 2030 (%, US$M)
Pharmaceutical cdmo market: Opportunity assessment by country
Global pharmaceutical cdmo market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
